Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Trugman

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|March 12, 1988
Cerebral arteritis and oral methylphenidateJ M Trugman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1995
D1/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiographyJ M Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1987
Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesionsJ M Trugman, G F Wooten
Brain Research|April 2, 1993
D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervationJ M Trugman, C L James
Neuropharmacology|June 1, 1989
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cellsI S Login, J M Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1992
Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiographyJ M Trugman, C L James
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonistsC A Hubbard, J M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
The dopamine motor systemG F Wooten, J M Trugman
Brain Research|August 6, 1986
The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigraJ M Trugman, G F Wooten
Advances in Neurology|September 29, 1998
Defects of biopterin metabolism and biogenic amine biosynthesis: clinical diagnostic, and therapeutic aspectsK Hyland, L A Arnold, J M Trugman
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 12, 1988
Cerebral arteritis and oral methylphenidateJ M Trugman
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 1995
D1/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiographyJ M Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1987
Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesionsJ M Trugman, G F Wooten
Brain Research|April 2, 1993
D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervationJ M Trugman, C L James
Neuropharmacology|June 1, 1989
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cellsI S Login, J M Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1992
Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiographyJ M Trugman, C L James
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonistsC A Hubbard, J M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
The dopamine motor systemG F Wooten, J M Trugman
Brain Research|August 6, 1986
The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigraJ M Trugman, G F Wooten
Advances in Neurology|September 29, 1998
Defects of biopterin metabolism and biogenic amine biosynthesis: clinical diagnostic, and therapeutic aspectsK Hyland, L A Arnold, J M Trugman
Pageof 4